Practice
Featured experience
InSilico Medicine HK$2.62 billion IPO
We advised InSilico Medicine on its IPO and HKEX listing
Mastercard $1.8 billion acquisition of BVNK
We are advising Mastercard on the transaction
Sycamore Partners up to $23.7 billion acquisition of Walgreens Boots Alliance
We are advising Sycamore Partners on the transaction
Comcast spinoff of select cable television networks
We are advising Comcast on the transaction
Deutsche Bank $1.5 billion notes offering
The fixed-to-floating-rate eligible liabilities senior notes are due 2029
Morgan Stanley $2 billion subordinated reset notes offering
We advised Morgan Stanley on its SEC-registered global offering
Morgan Stanley $4 billion senior notes offering
We advised Morgan Stanley on its SEC-registered global offering
Party City restructuring
We are advising an ad hoc group of first-lien noteholders in connection with Party City’s chapter 11 proceedings
Ruby Pipeline chapter 11 restructuring
We advised an ad hoc group of noteholders and the indenture trustee in connection with the restructuring
iQIYI $442 million follow-on offering
We advised the issuer on a follow-on offering of ADSs
Sun Pharmaceutical acquisition of Concert Pharmaceuticals
We advised Sun Pharmaceutical on the transaction
Toronto-Dominion Bank $100 million notes offering
The investment-grade notes are due 2028
CaixaBank $1.25 billion notes offering under $5 billion U.S. MTN program
The senior non-preferred callable fixed-to-floating-rate notes are due 2029
Expro $151.8 million secondary offering
The shares are listed on the NYSE